Hardman Johnston Global Advisors’s Novartis NVS Stock Holding History

Hardman Johnston Global Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,930	Closed	-$571K	–	75
2015 Q3	$571K	Sell	6,930 -78	-1%	-$6.94K	0.04%	61
2015 Q2	$618K	Sell	7,008 -246	-3%	-$22.6K	0.04%	63
2015 Q1	$641K	Sell	7,254 -13,548	-65%	-$1.2M	0.04%	66
2014 Q4	$1.73M	Sell	20,802 -636	-3%	-$52.7K	0.09%	62
2014 Q3	$1.81M	Sell	21,438 -9,219	-30%	-$746K	0.1%	59
2014 Q2	$2.49M	Sell	30,657 -1,874	-6%	-$147K	0.13%	55
2014 Q1	$2.48M	Sell	32,531 -4,654	-13%	-$339K	0.14%	56
2013 Q4	$2.68M	Buy	37,185 +3,482	+10%	+$242K	0.18%	53
2013 Q3	$2.32M	Sell	33,703 -8,326	-20%	-$551K	0.15%	53
2013 Q2	$2.66M	Buy	+42,029	New	+$2.73M	0.18%	53

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Hardman Johnston Global Advisors's NVS Position: Q4 2015 in Review

Hardman Johnston Global Advisors sold out of Novartis (NVS) in Q4 2015, closing a stake of 6,930 shares — an estimated $571K sold.

Hardman Johnston Global Advisors first reported a position in NVS in Q2 2013 and held it in 10 quarters. The position peaked at $2.68M in Q4 2013. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

Hardman Johnston Global Advisors reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
Hardman Johnston Global Advisors sold 6,930 Novartis shares in Q4 2015, an estimated $571K.
Hardman Johnston Global Advisors first reported a position in Novartis in Q2 2013 and held it in 10 quarters.
Hardman Johnston Global Advisors's Novartis position peaked at $2.68M in Q4 2013.
927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Hardman Johnston Global Advisors's 13F filing for Q4 2015, filed 9 Feb 2016.